サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1373766

患者血液管理の世界市場：市場規模、シェア、成長分析：タイプ別、用途別 - 業界予測

Global Patient Blood Management Market Size, Share, Growth Analysis, By Type(Instruments, Software and Consumables), By Application(Preoperative Anemia Management, Acute Blood Loss Management and Chronic Blood Loss Management) - Industry Forecast 2023-203
出版日: | 発行: SkyQuest | ページ情報: 英文 157 Pages | 納期: 3～5営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
患者血液管理の世界市場：市場規模、シェア、成長分析：タイプ別、用途別 - 業界予測
出版日: 2023年10月15日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日
  • 全表示
  • 概要
  • 目次
概要

世界の患者血液管理の市場規模は2021年に122億米ドル、2022年に129億7,000万米ドルとなりました。同市場は、予測期間中（2023年～2030年）に6.3%のCAGRで拡大し、2030年には211億4,000万米ドルに成長する見通しです。

世界の患者血液管理市場は、慢性疾患の有病率の上昇、外科手術の増加、患者血液管理戦略の利点に関する意識の高まりなど、さまざまな要因によって大きな成長を遂げています。患者血液管理（PBM）には、輸血を必要とする可能性のある患者のケアを最適化する包括的なアプローチが含まれ、患者の転帰を改善し、可能な限り輸血の必要性を減らすことを目的としています。世界市場の主な促進要因の一つは、心血管障害、がん、血液障害などの慢性疾患の有病率の上昇です。これらの疾患は外科的介入を必要とすることが多く、輸血の必要性を伴うことがあります。しかし、輸血にはリスクや合併症が伴うため、ヘルスケアプロバイダーは患者の血液管理戦略を採用し、輸血の使用を最小限に抑えるようになってきています。この動向は、患者血液管理ソリューションとサービスに対する需要に拍車をかけています。手術結果の改善、合併症の減少、入院期間の短縮が重視されているため、患者血液管理プロトコルの採用が促進され、市場の成長につながっています。輸血には、感染症、免疫反応、輸血関連合併症などさまざまなリスクが伴います。

輸血医学の分野は、血液管理のための斬新な技術や手法の出現別顕著な進歩を遂げてきました。これらの進歩により、輸血の安全性と有効性が大幅に改善され、患者血液管理の導入が促進されています。

患者血液管理の実施には、しばしば確立された輸血方法や医療規範からの逸脱が必要となります。変化への抵抗を克服し、医師の嗜好に対応し、適切なトレーニングと教育を提供することは、患者血液管理アプローチが広く受け入れられるための課題です。

当レポートは、世界の患者血液管理の市場について調査し、市場の概要とともに、タイプ別、用途別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

エグゼクティブサマリー

親市場分析

市場規模

  • 市場力学
  • 促進要因
  • 機会
  • 抑制要因
  • 課題

主要な市場の洞察

  • 技術分析
  • 価格分析
  • サプライチェーン分析
  • バリューチェーン分析
  • 市場のエコシステム
  • IP分析
  • 動向分析
  • スタートアップ分析
  • 原材料分析
  • イノベーションマトリックス
  • パイプライン製品分析
  • マクロ経済指標
  • トップ投資分析
  • 主な成功要因
  • 競合の程度

市場力学と見通し

  • 市場力学
  • 促進要因
  • 機会
  • 抑制要因
  • 課題
  • 規制状況
  • ポーター分析

世界の患者血液管理市場、タイプ別

  • 市場概要
  • 装置
  • ソフトウェアと消耗品

世界の患者血液管理市場、用途別

  • 市場概要
  • 術前貧血管理
  • 急性失血管理と慢性失血管理

世界の患者血液管理市場、地域別

  • 市場概要
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

競合情勢

  • 主要企業プロファイル
    • Fresenius SE &Co. KGaA
    • Haemonetics Corporation
    • Terumo Corporation
    • B. Braun Melsungen AG
    • Bio-Rad Laboratories, Inc.
    • LivaNova PLC
    • Medtronic PLC
    • Abbott Laboratories
    • Grifols, S.A
    • F. Hoffmann-La Roche Ltd
    • Danaher Corporation
    • Immucor, Inc.
    • BioMerieux SA
    • Ortho Clinical Diagnostics
    • Fresenius Kabi AG
    • Kedrion SpA
    • Octapharma AG
    • Beckman Coulter, Inc
    • Siemens Healthineers AG
    • Quidel Corporation
目次
Product Code: SQMIG35D2100

Global Patient Blood Management Market size was valued at USD 12.2 billion in 2021 and is poised to grow from USD 12.97 billion in 2022 to USD 21.14 billion by 2030, growing at a CAGR of 6.3% during the forecast period (2023-2030).

The global patient blood management market is experiencing significant growth, driven by various factors such as the rising prevalence of chronic diseases, increasing surgical procedures, and growing awareness about the benefits of patient blood management strategies. Patient blood management (PBM) involves a comprehensive approach to optimize the care of patients who might need blood transfusion, aiming to improve patient outcomes and reduce the need for blood transfusions whenever possible. One of the key drivers of the global market is the rising prevalence of chronic diseases, such as cardiovascular disorders, cancer, and blood disorders. These conditions often require surgical interventions, which may involve the need for blood transfusions. However, healthcare providers are increasingly adopting patient blood management strategies to minimize the use of blood transfusions, as they are associated with risks and complications. This trend is fueling the demand for patient blood management solutions and services. The emphasis on improving surgical outcomes, reducing complications, and shortening hospital stays is driving the adoption of patient blood management protocols, leading to market growth. Blood transfusions are associated with various risks, including infections, immune reactions, and transfusion-related complications.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Patient Blood Management Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Patient Blood Management Market Segmental Analysis

Global Patient Blood Management Market is segmented by type, application, and region. Based on type, the market can be segmented into Instruments, Software and Consumables. Based on application, the market is segmented into Preoperative Anemia Management, Acute Blood Loss Management and Chronic Blood Loss Management. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Patient Blood Management Market

Advancements in transfusion medicine

  • The field of transfusion medicine has experienced notable progress, marked by the emergence of novel techniques and technologies for blood management. These advancements have significantly improved the safety and effectiveness of blood transfusions, thereby encouraging the adoption of patient blood management practices.

Restraints in the Global Patient Blood Management Market

Challenges in changing transfusion practices

  • The implementation of patient blood management practices often necessitates a departure from established transfusion methods and medical norms. Overcoming resistance to change, accommodating physician preferences, and providing adequate training and education present challenges to the widespread acceptance of patient blood management approaches.

Market Trends of the Global Patient Blood Management Key

  • One significant market trend in the global patient blood management market is the increasing focus on personalized and evidence-based approaches to optimize blood transfusion practices. This trend emphasizes the importance of tailoring blood transfusion strategies to individual patients based on their specific needs and clinical conditions, rather than adopting a one-size-fits-all approach. Healthcare providers and organizations are recognizing the potential risks and complications associated with unnecessary blood transfusions, such as transfusion reactions, infections, and increased healthcare costs.

Table of Contents

  • Executive Summary
    • Market Overview
    • Wheel of Fortune
  • Research Methodology
    • Information Procurement
    • Secondary & Primary Data Sources
    • Market Size Estimation
    • Market Assumptions & Limitations
  • Parent Market Analysis
    • Market Overview
    • Market Size
    • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
  • Key Market Insights
    • Technology Analysis
    • Pricing Analysis
    • Supply Chain Analysis
    • Value Chain Analysis
    • Ecosystem of the Market
    • IP Analysis
    • Trade Analysis
    • Startup Analysis
    • Raw Material Analysis
    • Innovation Matrix
    • Pipeline Product Analysis
    • Macroeconomic Indicators
    • Top Investment Analysis
    • Key Success Factor
    • Degree of Competition
  • Market Dynamics & Outlook
    • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
    • Regulatory Landscape
    • Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
    • Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact
  • Global Patient Blood Management Market by Type
    • Market Overview
    • Instruments
    • Software and Consumables
  • Global Patient Blood Management Market by Application
    • Market Overview
    • Preoperative Anemia Management
    • Acute Blood Loss Management and Chronic Blood Loss Management
  • Global Patient Blood Management Market Size by Region
    • Market Overview
    • North America
  • USA
  • Canada
    • Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
    • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
    • Latin America
  • Brazil
  • Rest of Latin America
    • Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA
  • Competitive Landscape
    • Top 5 Player Comparison
    • Market Positioning of Key Players, 2021
    • Strategies Adopted by Key Market Players
    • Top Winning Strategies
  • By Development
  • By Company
  • By Year
    • Recent Activities in the Market
    • Key Companies Market Share (%), 2021
  • Key Company Profiles
    • Fresenius SE & Co. KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Haemonetics Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Bio-Rad Laboratories, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • LivaNova PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Medtronic PLC (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Abbott Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Grifols, S.A. (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • F. Hoffmann-La Roche Ltd (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Danaher Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Immucor, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • BioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Ortho Clinical Diagnostics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Fresenius Kabi AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Kedrion S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Octapharma AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Beckman Coulter, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Quidel Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments